Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial.
BMC Neurol
; 22(1): 205, 2022 Jun 03.
Article
in En
| MEDLINE
| ID: mdl-35659622
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Photophobia
/
Migraine Disorders
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
BMC Neurol
Journal subject:
NEUROLOGIA
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: